Literature DB >> 33782643

Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report.

Yoshikuni Yonenaga1,2, Manabu Kurosawa3, Shunichi Higashide1.   

Abstract

Serum Krebs von den Lungen-6 (KL-6) is clinically used for the diagnosis of interstitial pneumonia (IP) as well as the evaluation of its disease activity. A female patient was diagnosed with idiopathic IP when she was 62 years old. Four years later, serum levels of KL-6 had been elevated gradually from 2400-3821 U/ml, and she was found to have gallbladder cancer detected by contrast-enhanced computed tomography (CT) and 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT. She thus underwent a radical extended cholecystectomy. After the operation, serum levels of KL-6 showed a steep decline to 590 U/ml. Immunohistological examination revealed that KL-6 presented in gallbladder cancer cells. Taken together, serum KL-6 was shown to be produced by gallbladder cancer cells. Here, we present the first patient in whom increased serum KL-6 levels led to the diagnosis of gallbladder cancer during follow-up of IP. When serum levels of KL-6 are elevated during the follow-up care of IP despite no worsening of IP, an examination of the whole body should be performed to find possibly existing malignant tumors.
© The Author(s) 2021.

Entities:  

Keywords:  Gallbladder cancer; KL-6

Year:  2021        PMID: 33782643      PMCID: PMC7947111          DOI: 10.1007/s13691-020-00460-0

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  13 in total

1.  Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.

Authors:  T Kawamoto; J Shoda; T Irimura; N Miyahara; M Furukawa; T Ueda; T Asano; M Kano; N Koike; K Fukao; N Tanaka; T Todoroki
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  KL-6-producing invasive thymoma.

Authors:  Tadayoshi Kawata; Hideo Tsukagoshi; Toshiyuki Mashimo; Satoru Kakizaki; Takayuki Kasahara; Junko Iwasaki; Yuji Shimizu; Masatomo Mori
Journal:  Intern Med       Date:  2002-11       Impact factor: 1.271

Review 3.  Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.

Authors:  N Kohno
Journal:  J Med Invest       Date:  1999-08

4.  Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.

Authors:  Y Ogawa; T Ishikawa; K Ikeda; B Nakata; T Sawada; K Ogisawa; Y Kato; K Hirakawa
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

5.  Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.

Authors:  Naoko Fukuhara; Yoshinori Tanino; Suguru Sato; Atsuro Fukuhara; Manabu Uematsu; Takefumi Nikaido; Kenichi Misa; Yasuko Sato; Junpei Saito; Xintao Wang; Mitsuru Munakata
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2015-09-14       Impact factor: 0.670

6.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.

Authors:  H Kashiwagi; H Kijima; S Dowaki; Y Ohtani; K Tobita; M Tsukui; Y Tanaka; H Matsubayasi; T Tsuchida; H Yamazaki; M Nakamura; Y Ueyama; M Tanaka; T Tajima; H Makuuchi
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

Review 7.  Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition.

Authors:  Masaru Miyazaki; Masayuki Ohtsuka; Shuichi Miyakawa; Masato Nagino; Masakazu Yamamoto; Norihiro Kokudo; Keiji Sano; Itaru Endo; Michiaki Unno; Kazuo Chijiiwa; Akihiko Horiguchi; Hisafumi Kinoshita; Masaaki Oka; Keiichi Kubota; Masanori Sugiyama; Shinji Uemoto; Mitsuo Shimada; Yasuyuki Suzuki; Kazuo Inui; Susumu Tazuma; Junji Furuse; Akio Yanagisawa; Yasuni Nakanuma; Hiroshi Kijima; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2015-02-17       Impact factor: 7.027

8.  Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.

Authors:  Huanli Xu; Yoshinori Inagaki; Wei Tang; Qian Guo; Fengshan Wang; Yasuji Seyama; Yutaka Midorikawa; Ruoyan Gai; Noribim Kokudo; Yasuhiko Sugawara; Munehiro Nakata; Masatoshi Makuuchi
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

9.  A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer.

Authors:  Yohei Kida; Etsuko Maeshima; Kanako Furukawa; Tomohiro Ichikawa; Mikako Goda; Masakazu Ichinose
Journal:  Mod Rheumatol       Date:  2007-06-20       Impact factor: 3.023

10.  Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors.

Authors:  Mana Fukushima; Kayoko Higuchi; Hisashi Shimojo; Takeshi Uehara; Hiroyoshi Ota
Journal:  Acta Histochem Cytochem       Date:  2012-09-11       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.